BlackRock’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.1M | Buy |
6,160,422
+1,104,061
| +22% | +$17.6M | ﹤0.01% | 2169 |
|
|
2025
Q4 | $38.9M | Buy |
5,056,361
+345,919
| +7% | +$2.73M | ﹤0.01% | 2688 |
|
|
2025
Q3 | $34.7M | Buy |
4,710,442
+472,032
| +11% | +$2.42M | ﹤0.01% | 2738 |
|
|
2025
Q2 | $17M | Buy |
4,238,410
+3,181,392
| +301% | +$11.6M | ﹤0.01% | 3133 |
|
|
2025
Q1 | $3.36M | Sell |
1,057,018
-15,923
| -1% | -$75K | ﹤0.01% | 3803 |
|
|
2024
Q4 | $5.74M | Buy |
1,072,941
+469,064
| +78% | +$3.5M | ﹤0.01% | 3665 |
|
|
2024
Q3 | $3.19M | Buy |
603,877
+41,853
| +7% | +$150K | ﹤0.01% | 3858 |
|
|
2024
Q2 | $1.02M | Buy |
562,024
+39,046
| +7% | +$72.8K | ﹤0.01% | 4172 |
|
|
2024
Q1 | $931K | Buy |
522,978
+2,427
| +0.5% | +$5.07K | ﹤0.01% | 4216 |
|
|
2023
Q4 | $916K | Sell |
520,551
-700
| -0.1% | -$1.02K | ﹤0.01% | 4286 |
|
|
2023
Q3 | $761K | Sell |
521,251
-11,130
| -2% | -$23.5K | ﹤0.01% | 4314 |
|
|
2023
Q2 | $1.22M | Buy |
532,381
+39,159
| +8% | +$81.4K | ﹤0.01% | 4235 |
|
|
2023
Q1 | $449K | Buy |
493,222
+2,441
| +0.5% | +$1.91K | ﹤0.01% | 4553 |
|
|
2022
Q4 | $417K | Sell |
490,781
-12,161
| -2% | -$10.8K | ﹤0.01% | 4656 |
|
|
2022
Q3 | $411K | Sell |
502,942
-2,624
| -0.5% | -$2.5K | ﹤0.01% | 4782 |
|
|
2022
Q2 | $501K | Buy |
505,566
+6,092
| +1% | +$7.47K | ﹤0.01% | 4774 |
|
|
2022
Q1 | $819K | Sell |
499,474
-7,798
| -2% | -$14.3K | ﹤0.01% | 4727 |
|
|
2021
Q4 | $1.22M | Buy |
507,272
+406,821
| +405% | +$1.58M | ﹤0.01% | 4600 |
|
|
2021
Q3 | $486K | Sell |
100,451
-30,477
| -23% | -$90.2K | ﹤0.01% | 4760 |
|
|
2021
Q2 | $350K | Buy |
130,928
+53,260
| +69% | +$147K | ﹤0.01% | 4779 |
|
|
2021
Q1 | $239K | Buy |
77,668
+7,858
| +11% | +$28.4K | ﹤0.01% | 4716 |
|
|
2020
Q4 | $248K | Sell |
69,810
-91,739
| -57% | -$369K | ﹤0.01% | 4443 |
|
|
2020
Q3 | $647K | Sell |
161,549
-148,933
| -48% | -$595K | ﹤0.01% | 4216 |
|
|
2020
Q2 | $844K | Sell |
310,482
-4,795
| -2% | -$14.2K | ﹤0.01% | 4085 |
|
|
2020
Q1 | $664K | Buy |
315,277
+1,440
| +0.5% | +$5.85K | ﹤0.01% | 3993 |
|
|
2019
Q4 | $1.71M | Sell |
313,837
-20,259
| -6% | -$70.9K | ﹤0.01% | 3833 |
|
|
2019
Q3 | $1.01M | Buy |
334,096
+1,162
| +0.3% | +$4.88K | ﹤0.01% | 3980 |
|
|
2019
Q2 | $1.24M | Sell |
332,934
-589,026
| -64% | -$2.31M | ﹤0.01% | 3949 |
|
|
2019
Q1 | $3.71M | Sell |
921,960
-24,418
| -3% | -$103K | ﹤0.01% | 3518 |
|
|
2018
Q4 | $3.47M | Sell |
946,378
-260,142
| -22% | -$1.77M | ﹤0.01% | 3505 |
|
|
2018
Q3 | $10.3M | Buy |
1,206,520
+87,013
| +8% | +$870K | ﹤0.01% | 3220 |
|
|
2018
Q2 | $12.3M | Buy |
1,119,507
+382,389
| +52% | +$4.27M | ﹤0.01% | 3130 |
|
|
2018
Q1 | $8.5M | Buy |
737,118
+67,461
| +10% | +$638K | ﹤0.01% | 3202 |
|
|
2017
Q4 | $6.94M | Buy |
669,657
+289,096
| +76% | +$3.7M | ﹤0.01% | 3317 |
|
|
2017
Q3 | $6.07M | Buy |
380,561
+11,359
| +3% | +$157K | ﹤0.01% | 3407 |
|
|
2017
Q2 | $4.47M | Buy |
369,202
+190,584
| +107% | +$2.03M | ﹤0.01% | 3497 |
|
|
2017
Q1 | $3.71M | Buy |
178,618
+178,380
| +74,950% | +$2.79M | ﹤0.01% | 3475 |
|
|
2016
Q4 | $3K | Sell |
238
-200
| -46% | -$3.04K | ﹤0.01% | 3576 |
|
|
2016
Q3 | $7K | Buy |
438
+238
| +119% | +$3.43K | ﹤0.01% | 3446 |
|
|
2016
Q2 | $3K | Sell |
200
-11,800
| -98% | -$159K | ﹤0.01% | 3569 |
|
|
2016
Q1 | $174K | Buy |
+12,000
| New | +$172K | ﹤0.01% | 1767 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
PA